treatment pmc - Robuta Search

https://pmc.ncbi.nlm.nih.gov/articles/PMC3108697/ Antidepressant-associated sexual dysfunction: impact, effects, and treatment - PMC Sexual dysfunction is a common side effect of antidepressants and can have significant impact on the person’s quality of life, relationships, mental health,... sexual dysfunction treatment pmc antidepressant associated impact https://pmc.ncbi.nlm.nih.gov/articles/PMC3769077/ Paraphilias: definition, diagnosis and treatment - PMC There is a great deal of controversy concerning paraphilia, and defining what is normal versus deviant or disordered, given that this is to some degree... treatment pmc paraphilias definition diagnosis https://pmc.ncbi.nlm.nih.gov/articles/PMC5756804/ Delayed Ejaculation: Pathophysiology, Diagnosis, and Treatment - PMC Delayed ejaculation (DE) is a poorly defined and uncommon form of male sexual dysfunction, characterized by a marked delay in ejaculation or an inability to... delayed ejaculation pathophysiology diagnosis treatment pmc https://pmc.ncbi.nlm.nih.gov/articles/PMC2801586/ Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence - PMC Many men with erectile dysfunction (ED) also have associated underlying cardiovascular and metabolic conditions, for which they are likely to be taking... erectile dysfunction clinical evidence vardenafil treatment overview https://pmc.ncbi.nlm.nih.gov/articles/PMC7786299/ Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options - PMC Anxiety disorders are the most prevalent psychiatric disorders and a leading cause of disability. While there continues to be expansive research in... anxiety disorders treatment options pharmacotherapy current emerging https://pmc.ncbi.nlm.nih.gov/articles/PMC12781666/ Glucagon-like peptide and its receptor agonists for the treatment of rheumatic diseases - PMC Glucagon-like peptide-1 (GLP-1) and its receptor agonists (GLP-1RAs) are well-established therapies for metabolic conditions such as type 2 diabetes and... glucagon like peptide receptor agonists rheumatic diseases treatment pmc https://pmc.ncbi.nlm.nih.gov/articles/PMC3120123/ Toward Individualized Treatment for Substance Abuse - PMC substance abuse toward individualized treatment pmc https://pmc.ncbi.nlm.nih.gov/articles/PMC4203362/ Prize-based Contingency Management for the Treatment of Substance Abusers: A Meta-analysis - PMC To review randomized controlled trials to assess efficacy of a prize-based contingency management procedure in reducing substance use (where a drug-free breath... meta analysis pmc contingency management prize based treatment https://pmc.ncbi.nlm.nih.gov/articles/PMC4612133/ New and Emerging Treatment Options for Irritable Bowel Syndrome - PMC Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder associated with abdominal pain, diarrhea, constipation, or a mix of symptoms. The... irritable bowel syndrome treatment options new emerging pmc https://pmc.ncbi.nlm.nih.gov/articles/PMC7316362/ Zinc: The Wonder Drug for the Treatment of Carcinomas - PMC Evidence is evolving that support the relationship that all carcinomas exhibit the following important relationships: The malignant cells exhibit a significant... wonder drug zinc treatment carcinomas pmc https://pmc.ncbi.nlm.nih.gov/articles/PMC11762834/ Peptides: Emerging Candidates for the Prevention and Treatment of Skin Senescence: A Review - PMC One class of cosmetic compounds that have raised interest of many experts is peptides. The search for ingredients with good biocompatibility and bioactivity... skin senescence review pmc peptides emerging candidates https://pmc.ncbi.nlm.nih.gov/articles/PMC9945324/ GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach - PMC Obesity is a complex disease characterized by excessive fat accumulation which is caused by genetic, environmental and other factors. In recent years, there... receptor agonists promising approach treatment obesity role https://pmc.ncbi.nlm.nih.gov/articles/PMC2671940/ New agents in the treatment of premature ejaculation - PMC Premature ejaculation (PE) is a common male sexual disorder. Recent normative data suggest that men with an intravaginal ejaculatory latency time (IELT) of... new agents premature ejaculation treatment pmc https://pmc.ncbi.nlm.nih.gov/articles/PMC7498620/ Physical exercise in the prevention and treatment of Alzheimer's disease - PMC Low levels of physical activity are a risk factor associated with Alzheimer's disease. Older adults who exercise are more likely to maintain cognition.... physical exercise disease pmc prevention treatment alzheimer https://pmc.ncbi.nlm.nih.gov/articles/PMC1476026/ Nonpharmacologic Treatment of Erectile Dysfunction - PMC Nonpharmacologic treatment for erectile dysfunction (ED) includes sex therapy, the use of vacuum erection devices, penile prosthesis implantation, and penile... erectile dysfunction pmc treatment